Equity Overview
Price & Market Data
Price: $29.00
Daily Change: +$5.54 / 19.10%
Daily Range: $22.54 - $29.13
Market Cap: $2,199,481,344
Daily Volume: 108,455
Performance Metrics
1 Week: 84.62%
1 Month: 270.4%
3 Months: 62.60%
6 Months: 62.60%
1 Year: 62.60%
YTD: 186.2%
Company Details
Employees: 29
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. The company develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for the treatment of prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. Jyong Biotech Ltd. was founded in 2002 and is headquartered in New Taipei City, Taiwan.